Juno Therapeutics Garners $134,000,000 Series B Financing Round

  • Feed Type
  • Date
    8/5/2014
  • Company Name
    Juno Therapeutics
  • Mailing Address
    307 Westlake Avenue North Seattle, WA 98109 USA
  • Company Description
    Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
  • Website
    http://www.junotherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $134,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Our funding puts us in a strong position to move forward with multiple CAR-T and TCR therapies and invest in the science that will support continued innovation with these game-changing technologies.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.